Samuel Blackman
2021
In 2021, Samuel Blackman earned a total compensation of $2.9M as Co-Founder and Chief Medical Officer at Day One Biopharmaceuticals, a 515% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $205,000 |
|---|---|
| Option Awards | $1,815,322 |
| Salary | $422,568 |
| Stock Awards | $493,000 |
| Total | $2,935,891 |
Blackman received $1.8M in option awards, accounting for 62% of the total pay in 2021.
Blackman also received $205K in non-equity incentive plan, $422.6K in salary and $493K in stock awards.
Rankings
In 2021, Samuel Blackman's compensation ranked 4,511th out of 12,415 executives tracked by ExecPay. In other words, Blackman earned more than 63.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,511 out of 12,415 | 64th |
Division Manufacturing | 1,862 out of 5,505 | 66th |
Major group Chemicals And Allied Products | 776 out of 2,375 | 67th |
Industry group Drugs | 691 out of 2,096 | 67th |
Industry Pharmaceutical Preparations | 493 out of 1,546 | 68th |
Source: SEC filing on April 28, 2022.
Blackman's colleagues
We found two more compensation records of executives who worked with Samuel Blackman at Day One Biopharmaceuticals in 2021.